About Prof. Dr. I. Chiricuta Institute of Oncology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Prof. Dr. I. Chiricuta Institute of Oncology
During the past decade, Prof. Dr. I. Chiricuta Institute of Oncology conducted 57 clinical trials. In the 10-year time frame, 57 clinical trials started and 38 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 19 clinical trials were completed. i.e. 105.6%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Prof. Dr. I. Chiricuta Institute of Oncology" #1 sponsor was "Hoffmann-La Roche" with 29 trials, followed by "Amgen" with 6 trials
sponsored, "Helsinn Healthcare SA" with 4 trials sponsored, "OSI Pharmaceuticals" with 4 trials sponsored and "Pfizer"
with 4 trials sponsored. Other sponsors include 51 different institutions and
companies that sponsored additional 46 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Prof. Dr. I. Chiricuta Institute of Oncology"
#1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator, "ADIR, a Servier Group company" with 2 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator and "Breast International Group" with 2 trials as a collaborator. Other collaborators include 33 different institutions and companies that were
collaborators in the rest 39 trials.
Clinical Trials Conditions at Prof. Dr. I. Chiricuta Institute of Oncology
According to Clinical.Site data, the most researched conditions in "Prof. Dr. I. Chiricuta Institute of Oncology" are
"Breast Cancer" (13 trials), "Carcinoma, Non-Small-Cell Lung" (6 trials), "Metastatic Colorectal Cancer" (4 trials), "Non-Small Cell Lung Cancer" (4 trials) and "Renal Cell Carcinoma" (4 trials). Many other conditions were trialed in "Prof. Dr. I. Chiricuta Institute of Oncology" in a lesser frequency.
Clinical Trials Intervention Types at Prof. Dr. I. Chiricuta Institute of Oncology
Most popular intervention types in "Prof. Dr. I. Chiricuta Institute of Oncology" are "Drug" (98 trials), "Biological" (7 trials), "Other" (4 trials), "Radiation" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (20 trials), "Paclitaxel" (15 trials), "Carboplatin" (10 trials), "Atezolizumab" (7 trials) and "Cisplatin" (7 trials). Other intervention names were less common.
Clinical Trials Genders at Prof. Dr. I. Chiricuta Institute of Oncology
The vast majority of trials in "Prof. Dr. I. Chiricuta Institute of Oncology" are
90 trials for "All" genders, 11 trials for "Female" genders and 2 trials for "Male" genders.
Clinical Trials Status at Prof. Dr. I. Chiricuta Institute of Oncology
Currently, there are NaN active trials in "Prof. Dr. I. Chiricuta Institute of Oncology".
undefined are not yet recruiting,
14 are recruiting,
19 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 57 completed trials in Prof. Dr. I. Chiricuta Institute of Oncology,
undefined suspended trials,
and 12 terminated clinical trials to date.
Out of the total trials that were conducted in Prof. Dr. I. Chiricuta Institute of Oncology, 8 "Phase 1"
clinical trials were conducted, 30 "Phase 2" clinical
trials and 64 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 4 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of Prof. Dr. I. Chiricuta Institute of Oncology
Prof. Dr. I. Chiricuta Institute of Oncology has several departments that took part in Clinical trials: "Cluj Clinical County Hospital; Oncology Dept" - 5 trials